299 related articles for article (PubMed ID: 37020588)
1. Research progress on exosomes in podocyte injury associated with diabetic kidney disease.
Li J; Zheng S; Ma C; Chen X; Li X; Li S; Wang P; Chen P; Wang Z; Li W; Liu Y
Front Endocrinol (Lausanne); 2023; 14():1129884. PubMed ID: 37020588
[TBL] [Abstract][Full Text] [Related]
2. Podocyte injury of diabetic nephropathy: Novel mechanism discovery and therapeutic prospects.
Li X; Zhang Y; Xing X; Li M; Liu Y; Xu A; Zhang J
Biomed Pharmacother; 2023 Dec; 168():115670. PubMed ID: 37837883
[TBL] [Abstract][Full Text] [Related]
3. The Role of Podocytes and Podocyte-Associated Biomarkers in Diagnosis and Treatment of Diabetic Kidney Disease.
Kravets I; Mallipattu SK
J Endocr Soc; 2020 Apr; 4(4):bvaa029. PubMed ID: 32232184
[TBL] [Abstract][Full Text] [Related]
4. [Abnormality of renin-angiotensin system in podocyte dysfunction in diabetic kidney disease].
Shao DC; Lu LM
Sheng Li Ke Xue Jin Zhan; 2011 Aug; 42(4):246-50. PubMed ID: 22066414
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of progression of diabetic kidney disease mediated by podocyte mitochondrial injury.
Su J; Ye D; Gao C; Huang Q; Gui D
Mol Biol Rep; 2020 Oct; 47(10):8023-8035. PubMed ID: 32918716
[TBL] [Abstract][Full Text] [Related]
6. [The role of podocyte autophagy and endoplasmic reticulum stress in diabetic kidney disease].
Li R; Guo Z
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Feb; 34(2):221-224. PubMed ID: 35387735
[TBL] [Abstract][Full Text] [Related]
7. Research progress on multiple cell death pathways of podocytes in diabetic kidney disease.
Yang C; Zhang Z; Liu J; Chen P; Li J; Shu H; Chu Y; Li L
Mol Med; 2023 Oct; 29(1):135. PubMed ID: 37828444
[TBL] [Abstract][Full Text] [Related]
8. Glomerular endothelial cell injury and cross talk in diabetic kidney disease.
Fu J; Lee K; Chuang PY; Liu Z; He JC
Am J Physiol Renal Physiol; 2015 Feb; 308(4):F287-97. PubMed ID: 25411387
[TBL] [Abstract][Full Text] [Related]
9. Modes of podocyte death in diabetic kidney disease: an update.
Jiang A; Song A; Zhang C
J Nephrol; 2022 Jul; 35(6):1571-1584. PubMed ID: 35201595
[TBL] [Abstract][Full Text] [Related]
10. Glomerular podocytes in diabetic renal disease.
Podgórski P; Konieczny A; Lis Ł; Witkiewicz W; Hruby Z
Adv Clin Exp Med; 2019 Dec; 28(12):1711-1715. PubMed ID: 31851794
[TBL] [Abstract][Full Text] [Related]
11. MYDGF attenuates podocyte injury and proteinuria by activating Akt/BAD signal pathway in mice with diabetic kidney disease.
He M; Li Y; Wang L; Guo B; Mei W; Zhu B; Zhang J; Ding Y; Meng B; Zhang L; Xiang L; Dong J; Liu M; Xiang L; Xiang G
Diabetologia; 2020 Sep; 63(9):1916-1931. PubMed ID: 32588068
[TBL] [Abstract][Full Text] [Related]
12. Jiedu Tongluo Baoshen formula enhances podocyte autophagy and reduces proteinuria in diabetic kidney disease by inhibiting PI3K/Akt/mTOR signaling pathway.
Jin D; Liu F; Yu M; Zhao Y; Yan G; Xue J; Sun Y; Zhao D; Li X; Qi W; Wang X
J Ethnopharmacol; 2022 Jul; 293():115246. PubMed ID: 35398500
[TBL] [Abstract][Full Text] [Related]
13. Research advance in the mechanism for oxidative stress-induced podocyte injury in diabetic kidney disease.
Ao L; Xie Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 46(12):1403-1408. PubMed ID: 35232911
[TBL] [Abstract][Full Text] [Related]
14. Research progress on extracellular vesicles in the renal tubular injury of diabetic kidney disease.
Li S; Zheng S; Li J; Lin S; Li H; Wang P; Chen P; Ma C; Liu Y
Front Endocrinol (Lausanne); 2023; 14():1257430. PubMed ID: 37732129
[TBL] [Abstract][Full Text] [Related]
15. Store-operated Ca
Tao Y; Mallet RT; Mathis KW; Ma R
Exp Biol Med (Maywood); 2023 May; 248(5):425-433. PubMed ID: 36533574
[TBL] [Abstract][Full Text] [Related]
16. Research progress of natural active compounds on improving podocyte function to reduce proteinuria in diabetic kidney disease.
Gong L; Wang R; Wang X; Liu J; Han Z; Li Q; Jin Y; Liao H
Ren Fail; 2023; 45(2):2290930. PubMed ID: 38073545
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of mitochondrial fission protects podocytes from albumin-induced cell damage in diabetic kidney disease.
Tagaya M; Kume S; Yasuda-Yamahara M; Kuwagata S; Yamahara K; Takeda N; Tanaka Y; Chin-Kanasaki M; Nakae Y; Yokoi H; Mukoyama M; Ishihara N; Nomura M; Araki SI; Maegawa H
Biochim Biophys Acta Mol Basis Dis; 2022 May; 1868(5):166368. PubMed ID: 35202791
[TBL] [Abstract][Full Text] [Related]
18. Urinary exosomes from patients with diabetic kidney disease induced podocyte apoptosis via microRNA-145-5p/Srgap2 and the RhoA/ROCK pathway.
Han L; Wang S; Li J; Zhao L; Zhou H
Exp Mol Pathol; 2023 Dec; 134():104877. PubMed ID: 37952894
[TBL] [Abstract][Full Text] [Related]
19. Emerging role of podocyte autophagy in the progression of diabetic nephropathy.
Yasuda-Yamahara M; Kume S; Tagawa A; Maegawa H; Uzu T
Autophagy; 2015; 11(12):2385-6. PubMed ID: 26565953
[TBL] [Abstract][Full Text] [Related]
20. Serum amyloid A and inflammation in diabetic kidney disease and podocytes.
Anderberg RJ; Meek RL; Hudkins KL; Cooney SK; Alpers CE; Leboeuf RC; Tuttle KR
Lab Invest; 2015 Mar; 95(3):250-62. PubMed ID: 25531567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
